[PHARMA] QoQ Quarter Result on 31-Dec-2014 [#4]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
23-Feb-2015
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2014
Quarter
31-Dec-2014 [#4]
Profit Trend
QoQ- 145.38%
YoY- 76.32%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Quarter Result
30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 CAGR
Revenue 524,413 512,845 471,904 627,103 502,086 525,072 468,672 7.77%
PBT 25,337 25,056 38,612 37,854 24,945 24,622 38,159 -23.87%
Tax -5,362 -8,414 -6,686 -1,233 -9,944 -8,665 -11,513 -39.88%
NP 19,975 16,642 31,926 36,621 15,001 15,957 26,646 -17.46%
-
NP to SH 19,971 16,217 31,794 36,697 14,955 15,975 26,217 -16.57%
-
Tax Rate 21.16% 33.58% 17.32% 3.26% 39.86% 35.19% 30.17% -
Total Cost 504,438 496,203 439,978 590,482 487,085 509,115 442,026 9.19%
-
Net Worth 534,373 528,477 528,173 525,351 507,124 502,293 515,022 2.48%
Dividend
30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 CAGR
Div 23,312 18,134 18,123 31,055 20,698 10,356 10,352 71.72%
Div Payout % 116.73% 111.82% 57.00% 84.63% 138.41% 64.83% 39.49% -
Equity
30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 CAGR
Net Worth 534,373 528,477 528,173 525,351 507,124 502,293 515,022 2.48%
NOSH 259,027 259,057 258,908 258,794 258,737 258,914 258,805 0.05%
Ratio Analysis
30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 CAGR
NP Margin 3.81% 3.25% 6.77% 5.84% 2.99% 3.04% 5.69% -
ROE 3.74% 3.07% 6.02% 6.99% 2.95% 3.18% 5.09% -
Per Share
30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 CAGR
RPS 202.45 197.97 182.27 242.32 194.05 202.80 181.09 7.70%
EPS 7.71 6.26 12.28 14.18 5.78 6.17 10.13 -16.62%
DPS 9.00 7.00 7.00 12.00 8.00 4.00 4.00 71.62%
NAPS 2.063 2.04 2.04 2.03 1.96 1.94 1.99 2.42%
Adjusted Per Share Value based on latest NOSH - 258,794
30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 CAGR
RPS 36.39 35.58 32.74 43.51 34.84 36.43 32.52 7.77%
EPS 1.39 1.13 2.21 2.55 1.04 1.11 1.82 -16.43%
DPS 1.62 1.26 1.26 2.15 1.44 0.72 0.72 71.62%
NAPS 0.3708 0.3667 0.3665 0.3645 0.3519 0.3485 0.3573 2.50%
Price Multiplier on Financial Quarter End Date
30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 CAGR
Date 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 -
Price 6.50 7.13 6.00 4.58 4.63 4.61 4.46 -
P/RPS 3.21 3.60 3.29 1.89 2.39 2.27 2.46 19.39%
P/EPS 84.31 113.90 48.86 32.30 80.10 74.72 44.03 54.13%
EY 1.19 0.88 2.05 3.10 1.25 1.34 2.27 -34.95%
DY 1.38 0.98 1.17 2.62 1.73 0.87 0.90 32.93%
P/NAPS 3.15 3.50 2.94 2.26 2.36 2.38 2.24 25.49%
Price Multiplier on Announcement Date
30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 CAGR
Date 26/11/15 17/08/15 18/05/15 23/02/15 21/11/14 21/08/14 14/05/14 -
Price 6.50 5.65 6.91 5.28 4.45 4.62 4.70 -
P/RPS 3.21 2.85 3.79 2.18 2.29 2.28 2.60 15.07%
P/EPS 84.31 90.26 56.27 37.24 76.99 74.88 46.40 48.85%
EY 1.19 1.11 1.78 2.69 1.30 1.34 2.16 -32.77%
DY 1.38 1.24 1.01 2.27 1.80 0.87 0.85 38.09%
P/NAPS 3.15 2.77 3.39 2.60 2.27 2.38 2.36 21.20%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment